2010年的多发性硬化症：多发性硬化症监测与治疗的进展 - Suppr

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.

作者信息

Filippi Massimo

机构信息

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, University Hospital San Raffaele, Milan, Italy.

出版信息

Nat Rev Neurol. 2011 Feb;7(2):74-5. doi: 10.1038/nrneurol.2010.215.

DOI:10.1038/nrneurol.2010.215

PMID:21297650

Abstract

摘要

相似文献

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.

Nat Rev Neurol. 2011 Feb;7(2):74-5. doi: 10.1038/nrneurol.2010.215.

Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS.

Nat Rev Neurol. 2011 Jul 12;7(8):425-7. doi: 10.1038/nrneurol.2011.105.

New drugs may improve, complicate treatment for multiple sclerosis.

Nat Med. 2010 Mar;16(3):272. doi: 10.1038/nm0310-272.

[Development of oral therapies for multiple sclerosis--fingolimod, cladribine and other drugs].

Med Monatsschr Pharm. 2010 Apr;33(4):120-30; quiz 131-2.

ACS chemical neuroscience molecule spotlight on gilenya (fingolimod; FTY720).

ACS Chem Neurosci. 2011 Mar 16;2(3):116-7. doi: 10.1021/cn100113g.

Trial watch: Phase III promise for oral multiple sclerosis therapy.

Nat Rev Drug Discov. 2009 Feb;8(2):98. doi: 10.1038/nrd2821.

[Emerging treatments for multiple sclerosis].

Rev Med Suisse. 2010 Jun 2;6(251):1162-3.

Update on emerging therapies for multiple sclerosis.

Expert Rev Neurother. 2010 Aug;10(8):1259-62. doi: 10.1586/ern.10.98.

Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):931-2. doi: 10.1136/jnnp-2014-310013. Epub 2015 Apr 2.

Multiple sclerosis, immunomodulation, and immunizations: balancing the benefits.

Neurology. 2015 Mar 3;84(9):864-5. doi: 10.1212/WNL.0000000000001319. Epub 2015 Jan 30.

引用本文的文献

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.

PLoS One. 2016 Jan 4;11(1):e0146084. doi: 10.1371/journal.pone.0146084. eCollection 2016.

MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

J Mol Neurosci. 2014 Jan;52(1):131-7. doi: 10.1007/s12031-013-0138-x. Epub 2013 Nov 12.

本文引用的文献

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.

Brain. 2010 Jun;133(Pt 6):1602-11. doi: 10.1093/brain/awq085. Epub 2010 Apr 25.

Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group.

Expert Opin Pharmacother. 2010 May;11(7):1225-30. doi: 10.1517/14656561003677390.

Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis.

Arch Neurol. 2010 Apr;67(4):402-7. doi: 10.1001/archneurol.2010.21. Epub 2010 Feb 8.

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20.

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20.

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20.

MRI criteria for MS in patients with clinically isolated syndromes.

Neurology. 2010 Feb 2;74(5):427-34. doi: 10.1212/WNL.0b013e3181cec45c. Epub 2010 Jan 6.

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2007 Mar 27;68(13):977-84. doi: 10.1212/01.wnl.0000258545.73854.cf.

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703.

Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.

作者信息

Filippi Massimo

机构信息

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, University Hospital San Raffaele, Milan, Italy.

出版信息

Nat Rev Neurol. 2011 Feb;7(2):74-5. doi: 10.1038/nrneurol.2010.215.

DOI:10.1038/nrneurol.2010.215

PMID:21297650

Abstract

摘要

相似文献

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.

Nat Rev Neurol. 2011 Feb;7(2):74-5. doi: 10.1038/nrneurol.2010.215.

Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS.

Nat Rev Neurol. 2011 Jul 12;7(8):425-7. doi: 10.1038/nrneurol.2011.105.

New drugs may improve, complicate treatment for multiple sclerosis.

Nat Med. 2010 Mar;16(3):272. doi: 10.1038/nm0310-272.

[Development of oral therapies for multiple sclerosis--fingolimod, cladribine and other drugs].

Med Monatsschr Pharm. 2010 Apr;33(4):120-30; quiz 131-2.

ACS chemical neuroscience molecule spotlight on gilenya (fingolimod; FTY720).

ACS Chem Neurosci. 2011 Mar 16;2(3):116-7. doi: 10.1021/cn100113g.

Trial watch: Phase III promise for oral multiple sclerosis therapy.

Nat Rev Drug Discov. 2009 Feb;8(2):98. doi: 10.1038/nrd2821.

[Emerging treatments for multiple sclerosis].

Rev Med Suisse. 2010 Jun 2;6(251):1162-3.

Update on emerging therapies for multiple sclerosis.

Expert Rev Neurother. 2010 Aug;10(8):1259-62. doi: 10.1586/ern.10.98.

Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):931-2. doi: 10.1136/jnnp-2014-310013. Epub 2015 Apr 2.

Multiple sclerosis, immunomodulation, and immunizations: balancing the benefits.

Neurology. 2015 Mar 3;84(9):864-5. doi: 10.1212/WNL.0000000000001319. Epub 2015 Jan 30.

引用本文的文献

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.

PLoS One. 2016 Jan 4;11(1):e0146084. doi: 10.1371/journal.pone.0146084. eCollection 2016.

MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

J Mol Neurosci. 2014 Jan;52(1):131-7. doi: 10.1007/s12031-013-0138-x. Epub 2013 Nov 12.

本文引用的文献

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.

Brain. 2010 Jun;133(Pt 6):1602-11. doi: 10.1093/brain/awq085. Epub 2010 Apr 25.

Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group.

Expert Opin Pharmacother. 2010 May;11(7):1225-30. doi: 10.1517/14656561003677390.

Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis.

Arch Neurol. 2010 Apr;67(4):402-7. doi: 10.1001/archneurol.2010.21. Epub 2010 Feb 8.

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20.

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20.

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20.

MRI criteria for MS in patients with clinically isolated syndromes.

Neurology. 2010 Feb 2;74(5):427-34. doi: 10.1212/WNL.0b013e3181cec45c. Epub 2010 Jan 6.

Neurology. 2007 Mar 27;68(13):977-84. doi: 10.1212/01.wnl.0000258545.73854.cf.

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703.

Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032.

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献